3 hours Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 1,270 Shares MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) CFO Benjamin Hohl sold 1,270 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $27.51, for a total transaction of $34,937.70…
Business · Nasdaq 100 · SEC